Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis;Valor pronóstico de la NT-proBNP y adaptación de la puntuación de Monin en pacientes con estenosis aórtica asintomática

Revista Espanola de Cardiologia

Volumn 67, Issue 1, 2014, Pages 52-57

  Farré, Núria ^a,b   Gómez, Miquel ^a,b   Molina, Luis ^a,b   Cladellas, Mercedes ^a,b   Blé, Mireia ^b   Roqueta, Cristina ^c   Ascoeta, Maria Soledad ^b   Comin Colet, Josep ^b   Vila, Joan ^d   Bruguera, Jordi ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c Institute of Neuropsychiatry and Addictions INAD   (Spain)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Aortic valve stenosis; Echocardiography; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACCURACY; AGED; ANGINA PECTORIS; AORTA STENOSIS; AORTA VALVE; ARTICLE; ASYMPTOMATIC DISEASE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; DEATH; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FAINTNESS; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONIN SCORE; PROGNOSIS; PROSPECTIVE STUDY; VALIDITY; ALGORITHM; AORTIC VALVE STENOSIS; BLOOD; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84891835038     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2013.06.023     Document Type: Article

References (34)

1. I. Ferreira-González, J. Pinar-Sopena, A. Ribera, J.R. Marsal, P. Cascant, and T. González-Alujas et al. Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area Eur J Prev Cardiol 2012 Jun 7 10.1177/ 2047487312451238 [Epub ahead of print]
2. A. Vahanian, O. Alfieri, F. Andreotti, M.J. Antunes, G. Barón-Esquivias, and H. Baumgartner et al. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACT. Guidelines on the management of valvular heart disease Eur Heart J 33 2012 2451 2496
3. R.O. Bonow, B.A. Carabello, K. Chatterjee, A.C. De Leon Jr., D.P. Faxon, and M.D. Freed et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 52 2008 e1 e142
4. C.M. Otto, I.G. Burwash, M.E. Legget, B.I. Munt, M. Fujioka, and N.L. Healy et al. Prospective study of asymptomatic valvular aortic stenosis clinical, echocardiografic and exercise predictors of outcome Circulation 95 1997 2262 2270
5. P. Varadarajan, N. Kapoor, R.C. Bansal, and R.G. Pai Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis Ann Thorac Surg 82 2006 2111 2115
6. T. Kitai, S. Honda, Y. Okada, T. Tani, K. Kim, and S. Kaji et al. Clinical outcomes in non-surgically managed patients with very severe versus severe aortic stenosis Heart 97 2011 2029 2327
7. R. Rosenhek, R. Zilberszac, M. Schemper, M. Czerny, G. Mundigler, and S. Graf et al. Natural history of very severe aortic stenosis Circulation 121 2010 151 156
8. P.A. Pellika, M.E. Sarano, R.A. Nihimura, J.F. Malouf, K.R. Bailey, and C.G. Scott et al. Outcome of 622 adults wih asymptomatic, hemodinamically significant aortic stenosis during prolonged follow-up Circulation 111 2005 3290 3295
9. S.C. Malaisrie, P.M. McCarthy, E.C. McGee, R. Lee, V.H. Rigolin, and C.J. Davidson et al. Contemporary perioperative results of isolated aortic valve replacement for aortic stenosis Ann Thorac Surg 89 2010 751 756
10. D.H. Kang, S.J. Park, J.H. Rim, S.C. Yun, D.H. Kim, and J.M. Song et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis Circulation 121 2010 1502 1509
11. M.L. Brown, P.A. Pellikka, H.V. Schaff, C.G. Scott, C.J. Mullany, and T.M. Sundt et al. The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis J Thorac Cardiovasc Surg 135 2008 308 315
12. R.G. Pai, N. Kapoor, R.C. Bansal, and P. Varadarajan Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement Ann Thorac Surg 82 2006 2116 2122
13. R. Rosenhek, T. Binder, G. Porenta, I. Lang, G. Christ, and M. Schemper et al. Predictors of outcome in severe, asymptomatic aortic stenosis N Engl J Med 343 2000 611 617
14. I. Holme, T.R. Pedersen, K. Boman, K. Egstrup, E. Gerdts, and Y.A. Kesäniemi et al. A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis Heart 98 2012 377 383
15. P. Lancellotti, E. Donal, J. Magne, M. Moonen, K. O'Connor, and J.C. Daubert et al. Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay Heart 96 2010 1364 1371
16. R. Rajani, H. Rimington, and J. Chambers B-type natriuretic peptide and tissue doppler for predicting symptoms on treadmill exercise in apparently asymptomatic aortic stenosis J Heart Valve Dis 18 2009 565 571
17. S. Nistri, P. Faggiano, I. Olivotto, B. Papesso, T. Bordonali, and G. Vescovo et al. Hemodynamic progression and outcome of asymptomatic aortic stenosis in primary care Am J Cardiol 109 2012 718 723
18. J.L. Monin, P. Lancellotti, M. Monchi, P. Lim, E. Weiss, and L. Piérard et al. Risk score for predicting outcome in patients with asymptomatic aortic stenosis Circulation 120 2009 69 75
19. P. Lancellotti, F. Lebois, M. Simon, C. Tombeux, C. Chauvel, and L.A. Pierard Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis Circulation 112 Suppl 9 2005 I377 I382
20. A.M. Rafique, S. Biner, I. Ray, J.S. Forrester, K. Tolstrup, and R.J. Siegel Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis Am J Cardiol 104 2009 972 977
21. T. Saito, T. Muro, H. Takeda, E. Hyodo, S. Ehara, and Y. Nakamura et al. Prognostic value of aortic valve area index in asymptomatic patients with severe aortic stenosis Am J Cardiol 110 2012 93 97
22. O.G. Solberg, T. Ueland, R. Wergeland, C.P. Dahl, S. Aakhus, and P. Aukrust et al. High-sensitive troponin T and N-terminal-brain-natriuretic- peptide predict outcome in symptomatic aortic stenosis Scand Cardiovasc J 46 2012 278 285
23. J.A. Wagner, S. Störk, F. Weidemann, J. Strotmann, C. Fiedel, and G. Ertl et al. Natriuretic peptides and myocardial oxygen supply-to-demand ratio in patients with aortic stenosis Eur J Clin Invest 37 2007 463 471
24. J. Bergler-Klein, U. Klaar, M. Heger, R. Rosenhek, G. Mundigler, and H. Gabriel et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis Circulation 109 2004 2302 2308
25. M. Katz, F. Tarasoutchi, A.E. Pesaro, R.D. Lopez, G.S. Spina, and M.L. Vieira et al. Natriuretic peptides and long-term mortality in patients with severe aortic stenosis J Heart Valve Dis 21 2012 331 336
26. A. Clerico, M. Fontana, L. Zyw, C. Passino, and M. Emdin Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review Clin Chem 53 2007 813 822
27. A. Clerico, F.A. Recchia, C. Passino, and M. Emdin Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications Am J Physiol Heart Circ Physiol 290 2006 H17 H29
28. J.M. Verdu, J. Comin-Colet, M. Domingo, J. Lupon, M. Gomez, and L. Molina et al. Punto de corte óptimo de NT-proBNP para el diagnóstico de insuficiencia cardiaca mediante un test de determinación rápida en atención primaria Rev Esp Cardiol 65 2012 613 619
29. P. Lancellotti, M. Moonen, J. Magne, K. O'Connor, B. Cosyns, and E. Attena et al. Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis Am J Cardiol 105 2010 383 388
30. J. Bermejo, R. Odreman, J. Feijoo, M.M. Moreno, P. Gómez-Moreno, and M.A.J. García-Fernández Clinical efficacy of Doppler-echocardiographic indices of aortic valve stenosis: a comparative test-based analysis of outcome J Am Coll Cardiol 41 2003 142 151
31. A.E. Rieck, E. Gerdts, M.T. Lønnebakken, E. Bahlmann, G. Cioffi, and C. Gohlke-Bärwolf et al. Global LV load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial) Cardiovasc Ultrasound 10 2012 43
32. G. Melis, G. Frontera, G. Caldentey, A. Sahuquillo, C. Fernández-Palomeque, and J.F. Forteza et al. El análisis del flujo aórtico por ecocardiografía Doppler es útil en la estratificación pronóstica de los pacientes con estenosis aórtica grave con fracción de eyección normal Rev Esp Cardiol 66 2013 261 268
33. G. Cioffi, P. Faggiano, E. Vizzardi, L. Tarantini, D. Cramariuc, and E. Gerdts et al. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis Heart 97 2011 301 307
34. G. Cioffi, C. Mazzone, P. Faggiano, L. Tarantini, A. Di Lenarda, and T.E. Russo et al. Prognostic stratification by conventional echocardiography of patients with aortic stenosis: The «CAIMAN-ECHO Score» Echocardiography 30 2013 367 377